1-9 of 9
Yue Ren
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Results from a Multicenter, Phase 2 Study of Acalabrutinib, Venetoclax, Obinutuzumab (AVO) in a Population of Previously Untreated Patients with CLL Enriched for High-Risk Disease

Christine E. Ryan, Benjamin L. Lampson, Svitlana Tyekucheva, Liam R. Hackett, Yue Ren, Samantha J. Shupe, Stacey M. Fernandes, Jennifer L. Crombie, Samuel Ng, Austin I. Kim, Inhye E. Ahn, Matthew J Weinstock, Samantha Pazienza, Josie S. Montegaard, Victoria Patterson, Caron A. Jacobson, Ann S. LaCasce, Philippe Armand, David C. Fisher, Jon E. Arnason, Steve Lo, Adam Olszewski, Jennifer R. Brown, Matthew S. Davids
Journal: Blood
Blood (2022) 140 (Supplement 1): 837–838.
https://doi.org/10.1182/blood-2022-168003
Published: 2022
Journal Articles

Increased Comorbidities and Hospitalizations Associated with Idiopathic Multicentric Castleman Disease

Mateo Sarmiento Bustamante, Sheila K Pierson, Yue Ren, Daisy Alapat, Adam Bagg, Joshua D Brandstadter, Mary Jo Lechowicz, Hongzhe Lee, Gordan Srkalovic, Megan S. Lim, Frits van Rhee, David C Fajgenbaum
Journal: Blood
Blood (2022) 140 (Supplement 1): 6520–6521.
https://doi.org/10.1182/blood-2022-170102
Published: 2022
Journal Articles

Association of Clonal Hematopoiesis of Indeterminate Potential with Time to First Treatment, Incidence of Richter's Syndrome, and Overall Survival in Patients with Chronic Lymphocytic Leukemia

Abi Vijenthira, Aswin Sekar, Christopher J. Gibson, Stephen P. Martindale, Rayan Fardoun, Svitlana Tyekucheva, Yue Ren, Stacey M. Fernandes, Binyamin A. Knisbacher, Cynthia K. Hahn, Gad Getz, Catherine J. Wu, Matthew S. Davids, Jennifer R. Brown
Journal: Blood
Blood (2022) 140 (Supplement 1): 9868–9870.
https://doi.org/10.1182/blood-2022-163273
Published: 2022
Journal Articles

Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients Remain

Sheila K Pierson, MS, Yue Ren, Johnson Khor, Eric Haljasmaa, Jasira Ziglar, Katherine Floess, Erin NaPier, Faizaan Akhter, Amy Y Liu, Damilola Gibson, Karan Kanhai, MD PhD, Rabecka Martin, PhD, Amy Chadburn, MD, Gordan Srkalovic, MD PhD, Megan S. Lim, MD PhD, Corey Casper, MD MPH, Thomas S. Uldrick, MD MS, Elaine S. Jaffe, MD, Frits van Rhee, MD PhD, Hongzhe Lee, PhD, David C Fajgenbaum, MDMBA,MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 1540.
https://doi.org/10.1182/blood-2019-131367
Published: 2019
Journal Articles

Quantification of Plasma Proteins from Idiopathic Multicentric Castleman Disease Flares and Remissions Reveals 'Chemokine Storm' and Separates Clinical Subtypes

Sheila K Pierson, MS, Aaron James Stonestrom, MDPhD, Jason R Ruth, PhD, Dustin Shilling, PhD, Hongzhe Li, PhD, Yue Ren, MS, Katie Stone, BS, Frits van Rhee, MD PhD, David C Fajgenbaum, MDMBA,MSc
Journal: Blood
Blood (2017) 130 (Supplement 1): 3592.
https://doi.org/10.1182/blood.V130.Suppl_1.3592.3592
Published: 2017
Journal Articles

Preliminary Study on the Abnormal DNA Methylation in T Cells from the Patients with Immune Related Pancytopenia

Zonghong Shao, MD, Yue Ren, Rong Fu, PhD
Journal: Blood
Blood (2014) 124 (21): 5156.
https://doi.org/10.1182/blood.V124.21.5156.5156
Published: 2014
Journal Articles

Hypomethylation and Overexpression of CD70 in CD4 + T Cells of the Patients with Immuno-Related Pancytopenia

Zonghong Shao, MD, Yue Ren, Rong Fu, PhD
Journal: Blood
Blood (2014) 124 (21): 5157.
https://doi.org/10.1182/blood.V124.21.5157.5157
Published: 2014
Journal Articles

Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia

Artur Slupianek, Yashodhara Dasgupta, Shu-yue Ren, Ewa Gurdek, Milene Donlin, Margaret Nieborowska-Skorska, Fabrice Fleury, Tomasz Skorski
Journal: Blood
Blood (2011) 118 (4): 1062–1068.
https://doi.org/10.1182/blood-2010-09-307256
Published: 2011
Includes: Supplemental data
Journal Articles

Targeting Phosphotyrosine-315 In RAD51 Recombinase to Prevent BCR-ABL1 - Mediated Unfaithful Homeologous Recombination Repair.

Artur Slupianek, PhD, Yashodhara Dasgupta, Shu-yue Ren, PhD, Kimberly Cramer, Tomasz Skorski, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1190.
https://doi.org/10.1182/blood.V116.21.1190.1190
Published: 2010